Isolation and characterization of a pigmentless-conidium mutant of Aspergillus fumigatus with altered conidial surface and reduced virulence

Infection and Immunity

Volumn 65, Issue 12, 1997, Pages 5110-5117

  Jahn, Bernhard ^a,d   Koch, Andreas ^b   Schmidt, Axel ^c   Wanner, Gerhard ^b   Gehringer, Heike ^b   Bhakdi, Sucharit ^a   Brakhage, Axel A ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c BAYER AG   (Germany)

^d Inst of Med Microbiol and Hygiene   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE; LUMINOL; OXIDIZING AGENT; PIGMENT; REACTIVE OXYGEN METABOLITE;

ARTICLE; ASPERGILLUS FUMIGATUS; CHEMOLUMINESCENCE; CONTROLLED STUDY; FUNGUS MUTANT; FUNGUS MUTATION; FUNGUS SPORE; HOST RESISTANCE; IMMUNE DEFICIENCY; MONOCYTE; NONHUMAN; OPPORTUNISTIC INFECTION; OXIDATIVE STRESS; PNEUMONIA; PRIORITY JOURNAL; VIRULENCE;

EID: 0030729225     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.12.5110-5117.1997     Document Type: Article

References (51)

1. Arruda, L. K., B. J. Mann, and M. D. Chapman. 1992. Selective expression of a major allergen and cytotoxin, Asp f I, in Aspergillus fumigatus. Implications for the immunopathogenesis of Aspergillus-related diseases. J. Immunol. 149:3354-3359.
2. Arruda, L. K., T. A. Platts Mills, J. W. Fox, and M. D. Chapman. 1990. Aspergillus fumigatus allergen I, a major IgE-binding protein, is a member of the mitogillin family of cytotoxins. J. Exp. Med. 172:1529-1532.
3. Aufauvre-Brown, A., J. Cohen, and D. W. Holden. 1992. Use of randomly amplified polymorphic DNA markers to distinguish isolates of Aspergillus fumigatus. J. Clin. Microbiol. 30:2991-2993.
4. Babior, B. M. 1978. Oxygen-dependent microbial killing by phagocytes. N. Engl. J. Med. 298:659-668.
5. Bhakdi, S., U. Weller, I. Walev, E. Martin, D. Jonas, and M. Palmer. 1993. A guide to the use of pore-forming toxins for controlled permeabilization of cell membranes. Med. Microbiol. Immunol. 182:167-175.
6. Borgia, P. T., C. L. Dodge, L. E. Eagleton, and T. H. Adams. 1994 Bidrectional gene transfer between Aspergillus fumigatus and Aspergillus nidulans. FEMS Microbiol. Lett. 122:227-232.
7. Bouchara, J. P., G. Tronchin, G. Larcher, and D. Chabasse. 1995. The search for virulence determinants in Aspergillus fumigatus. Trends Microbiol. 3:327-330.
8. Brakhage, A. A., and J. Van den Brulle. 1995. Use of reporter genes to identify recessive trans-acting mutations specifically involved in the regulation of Aspergillus nidulans penicillin biosynthesis genes. J. Bacteriol. 177: 2781-2788.
9. Coulot, P., J. P. Bouchara, G. Renier, V. Annaix, C. Planchenault, G. Tronchin, and D. Chabasse. 1994. Specific interaction of Aspergillus fumigatus with fibrinogen and its role in cell adhesion. Infect. Immun. 62:2169-2177.
10. Denning, D. W. 1994. Invasive aspergillosis in immunocompromised patients. Curr. Opin. Infect. Dis. 7:456-462.
11. Denning, D. W., L. Hall, M. Jackson, and S. Mollis. 1995. Efficacy of D0870 compared with those of itraconazole and amphotericin B in two murine models of invasive aspergillosis. Antimicrob. Agents Chemother. 39:1809-1814.
12. Graybill, J. R., and J. Ahrens. 1985. Itraconazole treatment of murine aspergillosis. Sabouraudia 23:219-223.
13. Holden, D. W., C. M. Tang, and J. M. Smith. 1994. Molecular genetics of Aspergillus pathogenicity. Antonie Leeuwenhoek 65:251-255.
14. Jacobson, E. S., E. Hove, and H. S. Emery. 1995. Antioxidant function of melanin in black fungi. Infect. Immun. 63:4944-4945.
15. Jacobson, E. S., and S. B. Tinnell. 1993. Antioxidant function of fungal melanin. J. Bacteriol. 175:7102-7104.
16. Jahn, B., E. Martin, A. Stueden, and S. Bhakdi. 1995. Susceptibility testing of Candida albicans and Aspergillus species by a simple microtiter menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide assay. J. Clin. Microbiol. 33:661-667.
17. Jahn, B., A. Stueben, and S. Bhakdi. 1996. Colorimetric susceptibility testing for Aspergillus fumigatus: comparison of menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide and alamar blue tests. J. Clin. Microbiol. 34:2039-2041.
18. Kolattukudy, P. E., J. D. Lee, L. M. Rogers, P. Zimmerman, S. Ceselski, B. Fox, B. Stein, and E. A. Copelan. 1993. Evidence for possible involvement of an elastolytic serine protease in aspergillosis. Infect. Immun. 61:2357-2368.
19. Kramer, M. R., S. E. Marshall, V. A. Starnes, P. Gamherg, Z. Amitai, and J. Theodore. 1993. Infectious complications in heart-lung transplantation. Analysis of 200 episodes. Arch. Intern. Med. 153:2010-2016.
20. Kwon Chung, K. J., I. Polacheck, and T. J. Popkin. 1982. Melanin-lacking mutants of Cryptococcus neoformans and their virulence for mice. J. Bacteriol. 150:1414-1421.
21. Kwon Chung, K. J., and J. C. Rhodes. 1986. Encapsulation and melanin formation as indicators of virulence in Cryptococcus neoformans. Infect. Immun. 51:218-223.
22. Kwon-Chung, K. J., and J. E. Bennett. 1992. Aspergillosis, p. 201-247. In K. J. Kwon-Chung and J. E. Bennett (ed.), Medical mycology. Lea and Febiger, Philadelphia, Pa.
23. Lamy, B., M. Moutaouakil, J. P. Latge, and J. Davies. 1991. Secretion of a potential virulence factor, a fungal ribonucleotoxin, during human aspergillosis infections. Mol. Microbiol. 5:1811-1815.
24. Levitz, S. M., and R. D. Diamond. 1985. A rapid colorimetric assay of fungal viability with the tetrazolium salt MTT. J. Infect. Dis. 152:938-945.
25. Levitz, S. M., and R. D. Diamond. 1985. Mechanisms of resistance of Aspergillus fumigatus conidia to killing by neutrophils in vitro. J. Infect. Dis. 152:33-42.
26. Litzka, O., K. Bergh, and A. A. Brakhage. 1995. Analysis of the regulation of the Aspergillus nidulans penicillin biosynthesis gene AAT (PENDE), which encodes acyl coenzyme A:6-aminopenicillanic acid acyltransferase. Mol. Gen. Genet. 249:557-569.
27. Martin, E., and S. Bhakdi. 1991. Quantitative analysis of opsonophagocytosis and of killing of Candida albicans by human peripheral blood leukocytes by using flow cytometry. J. Clin. Microbiol. 29:2013-2023.
28. Martin, E., A. Stuben, A. Gorz, U. Weller, and S. Bhakdi. 1994. Novel aspect of amphotericin B action: accumulation in human monocytes potentiates killing of phagocytosed Candida albicans. Antimicrob. Agents Chemother. 38:13-22.
29. McWhinney, P. H., C. C. Kibbler, M. D. Hamon, O. P. Smith, L. Gandhi, L. A. Berger, R. K. Walesby, A. V. Hoffbrand, and H. G. Prentice. 1993. Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience. Clin. Infect. Dis. 17:397-404.
30. Monod, M., S. Paris, D. Sanglard, K. Jaton Ogay, J. Bille, and J. P. Latge. 1993. Isolation and characterization of a secreted metalloprotease of As- pergillus fumigatus. Infect. Immun. 61:4099-4104.
31. Monod, M., S. Paris, J. Sarfati, K. Jaton Ogay, P. Ave, and J. P. Latge. 1993. Virulence of alkaline protease-deficient mutants of Aspergillus fumigatus. FEMS Microbiol. Lett. 80:39-46.
32. Monod, M., G. Togni, L. Rahalison, and E. Frenk. 1991. Isolation and characterisation of an extracellular alkaline protease of Aspergillus fumigatus. J. Med. Microbiol. 35:23-28.
33. Moser, M., R. Crameri, G. Menz, T. Schneider, T. Dudler, C. Virchow, M. Gmachl, K. Blaser, and M. Suter. 1992. Cloning and expression of recombinant Aspergillus fumigatus allergen I/a (rAsp f I/a) with IgE binding and type I skin test activity. J. Immunol. 149:454-460.
34. Musial, C. E., F. R. Cockerill, and G. D. Roberts. 1988. Fungal infections of the immunocompromised host: clinical and laboratory aspects. Clin. Microbiol. Rev. 1:349-364.
35. Paris, S., M. Monod, M. Diaquin, B. Lamy, L. K. Arruda, P. J. Punt, and J. P. Latge. 1993. A transformant of Aspergillus fumigatus deficient in the antigenic cytotoxin ASPFI. FEMS Microbiol. Lett. 111:31-36.
36. Raeder, U., and P. Broder. 1985. Rapid preparation of DNA from filamentous fungi. Lett. Appl. Microbiol. 1:17-20.
37. Reichard, U., S. Buttner, H. Eiffert, F. Staib, and R. Ruchel. 1990. Purification and characterisation of an extracellular serine proteinase from Aspergillus fumigatus and its detection in tissue. J. Med. Microbiol. 33:243-251.
38. Reichard, U., M. Monod, and R. Ruchel. 1995. Molecular cloning and sequencing of the gene encoding an extracellular aspartic proteinase from Aspergillus fumigatus. FEMS Microbiol. Lett. 130:69-74.
39. Roilides, E., A. Holmes, C. Blake, D. Venzon, P. A. Pizzo, and T. J. Walsh. 1994. Antifungal activity of elutriated human monocytes against Aspergillus fumigatus hyphae: Enhancement by granulocyte-macrophage colony-stimulating factor and interferon-gamma. J. Infect. Dis. 170:894-899.
40. Roilides, E., K. Uhlig, D. Venzon, P. A. Pizzo, and T. J. Walsh. 1993. Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon. Infect. Immun. 61: 4870-4877.
41. Rowlands, R. T., and G. Turner. 1973. Nuclear and extranuclear inheritance of oligomycin resistance in Aspergillus nidulans. Mol. Gen. Genet. 126:201-216.
42. Smith, J. M., C. M. Tang, S. Van Noorden, and D. W. Holden. 1994. Virulence of Aspergillus fumigatus double mutants lacking restriction and an alkaline protease in a low-dose model of invasive pulmonary aspergillosis. Infect. Immun. 62:5247-5254.
43. Stephan, J. L., V. Vlekova, F. Le Deist, S. Blanche, J. Donadieu, G. De Saint Basile, A. Durandy, C. Griscelli, and A. Fischer. 1993. Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients. J. Pediatr. 123:564-572.
44. Tronchin, G., J. P. Bouchara, G. Larcher, J. C. Lissitzky, and D. Chabasse. 1993. Interaction between Aspergillus fumigatus and basement membrane laminin: binding and substrate degradation. Biol. Cell 77:201-208.
45. Van Cutsem, J., F. Van Gerven, and P. A. Janssen. 1987. Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycoses: animal models. Rev. Infect. Dis. 9(Suppl. 1): S15-S32.
46. Wang, Y., P. Aisen, and A. Casadevall. 1995. Cryptococcus neoformans melanin and virulence: mechanism of action. Infect. Immun. 63:3131-3136.
47. Wang, Y., and A. Casadevall. 1994. Susceptibility of melanized and nonmelanized Cryptococcus neoformans to nitrogen- and oxygen-derived oxidants. Infect. Immun. 62:3004-3007.
48. Washburn, R. G., J. I. Gallin, and J. E. Bennett. 1987. Oxidative killing of Aspergillus fumigatus proceeds by parallel myeloperoxidase-dependent and -independent pathways. Infect. Immun. 55:2088-2092.
49. Watson, F., J. Robinson, and S. W. Edwards. 1991. Protein kinase C-dependent and -independent activation of the NADPH oxidase of human neutrophils. J. Biol. Chem. 266:7432-7439.
50. Yamaguchi, H. 1987. Opportunistic fungal infections, p. 101-158. In M. Miyaji (ed.), Animal models in medical mycology. CRC Press, Boca Raton, Fla.
51. Zuger, A., E. Louie, R. S. Holzman, M. S. Simberkoff, and J. J. Rahal. 1986. Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment. Ann. Intern. Med. 104:234-240.